GKOS

Glaukos (GKOS)

Glaukos Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:GKOS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/04	10 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/06/04	09 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/06/04	09 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/06/04	09 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/06/04	09 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/06/04	09 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/06/04	09 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/06/04	05 : 25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:GKOS	Glaukos Corporation
2024/05/31	05 : 45	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NYSE:GKOS	Glaukos Corporation
2024/05/31	00 : 33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:GKOS	Glaukos Corporation
2024/05/28	20 : 00	Business Wire	Glaukos Announces Participation in Upcoming Investor Conferences	NYSE:GKOS	Glaukos Corporation
2024/05/20	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:GKOS	Glaukos Corporation
2024/05/17	08 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/05/16	04 : 37	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:GKOS	Glaukos Corporation
2024/05/15	05 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/05/15	05 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/05/11	06 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:GKOS	Glaukos Corporation
2024/05/11	05 : 30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:GKOS	Glaukos Corporation
2024/05/09	06 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/05/09	06 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/05/07	06 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/05/07	06 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation
2024/05/07	05 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:GKOS	Glaukos Corporation
2024/05/07	04 : 40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:GKOS	Glaukos Corporation
2024/05/02	05 : 05	Business Wire	Glaukos Announces First Quarter 2024 Financial Results	NYSE:GKOS	Glaukos Corporation
2024/04/17	05 : 05	Business Wire	Glaukos Announces the Release of its 2023 Sustainability Report	NYSE:GKOS	Glaukos Corporation
2024/04/10	20 : 00	Business Wire	Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1	NYSE:GKOS	Glaukos Corporation
2024/04/03	20 : 00	Business Wire	Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)	NYSE:GKOS	Glaukos Corporation
2024/04/01	20 : 00	Business Wire	Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting	NYSE:GKOS	Glaukos Corporation
2024/03/09	07 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GKOS	Glaukos Corporation